Pay in 4 interest-free payments of $5.75 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
While there is limited published data specifically examining intramuscular administration of tirzepatide, extrapolation from pharmacokinetic principles and experience with other subcutaneous medications suggests several potential concerns
En la medida de lo posible, no iniciar nuevos tratamientos hasta que los titulares confirmen que pueden abastecer la demanda
2024;23(5):e13424
GLP-1 receptor agonists like semaglutide and tirzepatide are approved by the FDA for chronic weight management in adults with obesity or overweight with weight-related conditions, with documented efficacy showing average weight loss of 15-22% in clinical trials
US$ 28.07
US$ 28.21
US$ 22.45
